Literature DB >> 33103564

CBP80/20-dependent translation initiation factor (CTIF) inhibits HIV-1 Gag synthesis by targeting the function of the viral protein Rev.

Francisco García-de-Gracia1,2, Aracelly Gaete-Argel1,2, Sebastián Riquelme-Barrios1,2, Camila Pereira-Montecinos1,2, Bárbara Rojas-Araya1,2, Paulina Aguilera1,2, Aarón Oyarzún-Arrau1,2, Cecilia Rojas-Fuentes1,2, Mónica L Acevedo1, Jonás Chnaiderman1, Fernando Valiente-Echeverría1,2, Daniela Toro-Ascuy1,2, Ricardo Soto-Rifo1,2.   

Abstract

Translation initiation of the human immunodeficiency virus type-1 (HIV-1) full-length RNA has been shown to occur through cap-dependent and IRES-driven mechanisms. Previous studies suggested that the nuclear cap-binding complex (CBC) rather than eIF4E drives cap-dependent translation of the full-length RNA and we have recently reported that the CBC subunit CBP80 supports the function of the viral protein Rev during nuclear export and translation of this viral transcript. Ribosome recruitment during CBC-dependent translation of cellular mRNAs relies on the activity CBP80/20 translation initiation factor (CTIF), which bridges CBP80 and the 40S ribosomal subunit through interactions with eIF3g. Here, we report that CTIF inhibits HIV-1 and HIV-2 Gag synthesis from the full-length RNA. Our results indicate that CTIF associates with HIV-1 Rev through its N-terminal domain and is recruited onto the full-length RNA ribonucleoprotein complex in order to interfere with Gag synthesis. We also demonstrate that CTIF induces the cytoplasmic accumulation of Rev impeding the association of the viral protein with CBP80. We finally show that Rev interferes with the association of CTIF with CBP80 indicating that CTIF and Rev compete for the CBC subunit.

Entities:  

Keywords:  CBP80; CTIF; Gag synthesis; HIV-1 Rev; HIV-1 full-length RNA

Mesh:

Substances:

Year:  2020        PMID: 33103564      PMCID: PMC8078705          DOI: 10.1080/15476286.2020.1832375

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  53 in total

Review 1.  Translation initiation of the HIV-1 mRNA.

Authors:  Théophile Ohlmann; Chloé Mengardi; Marcelo López-Lastra
Journal:  Translation (Austin)       Date:  2014-10-31

2.  SUnSET, a nonradioactive method to monitor protein synthesis.

Authors:  Enrico K Schmidt; Giovanna Clavarino; Maurizio Ceppi; Philippe Pierre
Journal:  Nat Methods       Date:  2009-03-22       Impact factor: 28.547

3.  NXF1 and CRM1 nuclear export pathways orchestrate nuclear export, translation and packaging of murine leukaemia retrovirus unspliced RNA.

Authors:  M Mougel; C Akkawi; C Chamontin; J Feuillard; L Pessel-Vivares; M Socol; S Laine
Journal:  RNA Biol       Date:  2020-01-23       Impact factor: 4.652

4.  eIF4AIII enhances translation of nuclear cap-binding complex-bound mRNAs by promoting disruption of secondary structures in 5'UTR.

Authors:  Junho Choe; Incheol Ryu; Ok Hyun Park; Joori Park; Hana Cho; Jin Seon Yoo; Sung Wook Chi; Min Kyung Kim; Hyun Kyu Song; Yoon Ki Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

5.  Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism.

Authors:  B Chesebro; K Wehrly; J Nishio; S Perryman
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

6.  The human immunodeficiency virus type 1 5' packaging signal structure affects translation but does not function as an internal ribosome entry site structure.

Authors:  G Miele; A Mouland; G P Harrison; E Cohen; A M Lever
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

7.  The leader of human immunodeficiency virus type 1 genomic RNA harbors an internal ribosome entry segment that is active during the G2/M phase of the cell cycle.

Authors:  Ann Brasey; Marcelo Lopez-Lastra; Theophile Ohlmann; Nancy Beerens; Ben Berkhout; Jean-Luc Darlix; Nahum Sonenberg
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

8.  Functional comparison of the Rev trans-activators encoded by different primate immunodeficiency virus species.

Authors:  M H Malim; S Böhnlein; R Fenrick; S Y Le; J V Maizel; B R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

9.  Thriving under stress: selective translation of HIV-1 structural protein mRNA during Vpr-mediated impairment of eIF4E translation activity.

Authors:  Amit Sharma; Alper Yilmaz; Kim Marsh; Alan Cochrane; Kathleen Boris-Lawrie
Journal:  PLoS Pathog       Date:  2012-03-22       Impact factor: 6.823

10.  HIV-1 intron-containing RNA expression induces innate immune activation and T cell dysfunction.

Authors:  Hisashi Akiyama; Caitlin M Miller; Chelsea R Ettinger; Anna C Belkina; Jennifer E Snyder-Cappione; Suryaram Gummuluru
Journal:  Nat Commun       Date:  2018-08-27       Impact factor: 14.919

View more
  4 in total

Review 1.  Anomalous HIV-1 RNA, How Cap-Methylation Segregates Viral Transcripts by Form and Function.

Authors:  Kathleen Boris-Lawrie; Gatikrushna Singh; Patrick S Osmer; Dora Zucko; Seth Staller; Xiao Heng
Journal:  Viruses       Date:  2022-04-29       Impact factor: 5.818

Review 2.  NCBP3: A Multifaceted Adaptive Regulator of Gene Expression.

Authors:  Xavier Rambout; Lynne E Maquat
Journal:  Trends Biochem Sci       Date:  2020-10-05       Impact factor: 13.807

3.  Epitranscriptomic regulation of HIV-1 full-length RNA packaging.

Authors:  Camila Pereira-Montecinos; Daniela Toro-Ascuy; Catarina Ananías-Sáez; Aracelly Gaete-Argel; Cecilia Rojas-Fuentes; Sebastián Riquelme-Barrios; Bárbara Rojas-Araya; Francisco García-de-Gracia; Paulina Aguilera-Cortés; Jonás Chnaiderman; Mónica L Acevedo; Fernando Valiente-Echeverría; Ricardo Soto-Rifo
Journal:  Nucleic Acids Res       Date:  2022-02-28       Impact factor: 19.160

Review 4.  HibeRNAtion: HIV-1 RNA Metabolism and Viral Latency.

Authors:  Raquel Crespo; Shringar Rao; Tokameh Mahmoudi
Journal:  Front Cell Infect Microbiol       Date:  2022-06-14       Impact factor: 6.073

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.